common.study.topics.clinical

RAPA-Keloid Study of Keloid Regression

common.study.values.description

“RAPA-Keloid Study of Keloid Regression”

1. To test whether topical rapamycin regresses established keloids in humans by measuring surface area and height changes in the scar over time (6 months) 2. To test safety of product and feasibility of conduct for future clinical trial

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Rapamycin 8% Ointment

A compounded ointment containing 8% rapamycin

Drug - Placebo

Petrolatum ointment placebo

participant.views.study.view.additional

participant.views.study.view.scientific-title

Effect of Topical Rapamycin Ointment on Keloid Regression: A Pilot Study in Human Subjects (RAPA-Keloid)

common.study.values.clinical-trial-id

NCT04049552

participant.views.study.view.id

e9rwBa